IDegAsp: a novel soluble insulin analogs combination (Q38040422)

27 August 2017

IDegAsp: a novel soluble insulin analogs combination (English)

1 reference

27 August 2017

1 reference

Zhulin Ma

1

1 reference

27 August 2017

Tina Parkner

series ordinal

2

1 reference

27 August 2017

Jens Sandahl Christiansen

series ordinal

3

1 reference

27 August 2017

Torben Laursen

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

4 September 2012

1 reference

Expert Opinion on Biological Therapy

27 August 2017

1 reference

27 August 2017

12

1 reference

27 August 2017

11

1 reference

27 August 2017

1533-1540

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

27 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Standards of medical care in diabetes--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

A review of human and analogue insulin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Clinical pharmacokinetics and pharmacodynamics of insulin glulisine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Controversies in the use of insulin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Clinical pharmacokinetics and pharmacodynamics of insulin aspart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.722203

10.1517/14712598.2012.722203

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference